Fig. 1From: Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancerExpression of Bcl-xL, Bcl-2, and Mcl-1 in HNSCC. Western blot analysis demonstrating the expression of the anti-apoptotic proteins Bcl-xL, Bcl-2, and Mcl-1 in four different head and neck cancer cell lines, UM-SCC-11B, UM-SCC-14C, UM-SCC-22A and VU-SCC-OEBack to article page